AzTrials
AzTrials

Hemodialysis PatientNCT07677605

A Theory-based Fluid Self-management Program

A study testing A Theory-based fluid self-management program in people with Hemodialysis Patient, run by National Taipei University of Nursing and Health Sciences at 1 site in Indonesia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the efficacy of an intervention guided by the IFSMT, in which structured education and digitally delivered reinforcement strategies are designed to enhance self-management processes, including knowledge and beliefs, self-regulation skills, and social facilitation, among patients undergoing… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hemodialysis Patient
What is being tested?
A Theory-based fluid self-management program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteIndonesia
Study dates
1 Jul 2026to 28 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Receiving maintenance hemodialysis for ≥ 3 months
  • Undergoing hemodialysis two times per week on a regular schedule
  • Possession of a smartphone with active WhatsApp use
  • Ability to read and understand Indonesian, with support provided in Javanese where necessary.
  • Provision of written informed consent

Who cannot join

  • Severe cognitive impairment or diagnosed psychiatric disorders affecting comprehension or participation, as documented in the medical record.
  • Severe visual, hearing, or communication impairments not corrected by assistive devices
  • Current hospitalisation or unstable medical condition
  • Planned kidney transplantation or dialysis modality change during the study period
  • Participation in another interventional study related to fluid management or self-management
  • Inability to engage with the WhatsApp Channel follow-up

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Cornelia Dede Yoshima Nekada, PhD Candidate contact

+628121444251

lia.nekada@gmail.com

Tsae-Jyy (Tiffany) Wang, PhD contact

+886228227101 ext. 2300

tsaejyy@ntunhs.edu.tw

Indonesia1 site
  • Dr. Soeradji Tirtonegoro General Hospital l. Dr. Soeradji Tirtonegoro No.1, Dusun 1, Tegalyoso

    Klaten, Central Java, 57424

    Agus Suharto, S.Kep.Ners.MARS, Master, +6283867764860, agussuhartomistik@gmail.com

Other trials in Indonesia

About this study

Official title: Effects of Self-Management Program on Interdialytic Weight Gain Control in Hemodialysis Patients: A Randomized Controlled Trial

This study aims to evaluate the efficacy of an intervention guided by the IFSMT, in which structured education and digitally delivered reinforcement strategies are designed to enhance self-management processes, including knowledge and beliefs, self-regulation skills, and social facilitation, among patients undergoing maintenance hemodialysis. The intervention, delivered via a mobile platform three times daily over two months, seeks to improve fluid control adherence and hemodialysis self-management behaviours, and to reduce interdialytic weight gain and stabilise pre-hemodialysis mean arterial pressure, compared with standard education alone.

Read the detailed description

The intervention implementation process includes: (1) PowerPoint presentations for group and individual education sessions; (2) a social support system using a WhatsApp Channel as a follow-up platform; (3) individual management and monitoring through a diary tracking fluid intake and symptoms of illness; (4) distribution of visual educational materials using digital stickers and posters on the WhatsApp Channel. Educational materials include: (1) Self-Management of Hemodialysis Treatment; (2) Fluid Intake Control; (3) Self-Management of Nutritional Needs; (4) Self-Management in Seeking Information Sources; (5) Emotional State Management. The intervention was conducted at Dr. Soeradji Tirtionegoro General Hospital in Klaten and Panembahan Senopati Regional General Hospital in Bantul. The intervention was implemented through: (1) in-person classes; (2) individual bedside education during hemodialysis sessions; (3) a WhatsApp Channel as a platform for providing social support related to the educational materials provided. The delivery of this education prioritized patient-centered communication and active patient participation. Group education sessions lasted 60 minutes and were held once after the initial data collection, while individual education sessions lasted 10 minutes and were held once a week according to the patients' hemodialysis schedules for 8 weeks. Monitoring and social support were provided three times a day at 9:00, 14:00, and 19:00 WIB for 8 weeks. The digital logbook was updated once a day for 8 weeks. This intervention is individually tailored to each patient's learning needs, literacy level, self-management barriers, eating habits, psychosocial conditions, and clinical issues identified during dialysis sessions. Any changes that occur during the study-including adjustments to the educational focus based on the patient's level of understanding, dialysis complications, or scheduling constraints-will be documented by the research team. Adherence to the intervention was ensured through: (1) standardized intervention guidelines; (2) training for the research team's nurses; (3) the use of a structured follow-up checklist; (4) routine monitoring meetings led by the principal investigator; and (6) periodic observations of the intervention's implementation. The principal investigator evaluated adherence to the intervention weekly to ensure consistency among the educators. The number of educational sessions completed, session duration, participant attendance, and completion of follow-up visits will be documented throughout the study. Any deviations from the intervention protocol will be recorded and analyzed

Being tested
A Theory-based fluid self-management program
Keywords
Fluid-Self Management Program, Interdialytic Weight Gain Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A Theory-based fluid self-management programBehavioural

    Also called Interdialytic Weight Gain Control in Hemodialysis Patients

    The intervention intervention process includes: (1) PowerPoint presentations for group and individual education sessions; (2) a social support system using a WhatsApp Channel as a follow-up platform; (3) individual management and monitoring through a diary tracking fluid intake and symptoms of illness; (4) distribution of visual educational materials using digital stickers and posters on the WhatsApp Channel.

Study groups in NCT07677605
Study groupRoleWhat they receive
A Theory-based fluid self-management programExperimentalThe intervention implementation process includes: (1) PowerPoint presentations for group and individual education sessions; (2) a social support system using a WhatsApp Channel as a follow-up platform; (3) individual management and monitoring through a diary tracking fluid intake and symptoms of illness; (4) distribution of visual educational materials using digital stickers and posters on the WhatsApp Channel.
Receives: Behavioral: A Theory-based fluid self-management program
Control Group For A Theory-based fluid self-management programNo interventionUsing standar routine for health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Interdialytic Weight Gain

    The percentage increase (%) in body weight between two hemodialysis sessions, calculated as the difference between the current pre-hemodialysis body weight and the post-hemodialysis body weight from the previous session, divided by the prescribed dry weight set by the nephrologist. Using percentage (%) as a unit, with rasio scale (continuos variable), and data source by medical record

    Measured: Each participant's hemodialysis sessions over an eight-month period

  2. Mean Arterial Pressure

    The mean arterial pressure, which reflects organ perfusion, is calculated based on systolic and diastolic blood pressure measurements taken with a calibrated sphygmomanometer before and after the hemodialysis session. Using percentage (mmHg) as a unit, with rasio scale (continuos variable), and data source by medical record

    Measured: Each participant's hemodialysis sessions over an eight-month period

Secondary outcomes (2)
  1. Fluid Adherence in Hemodialysis Patients

    The patient completes a self-reported FCHPS (Fluid Control in Hemodialysis Patients Scale) questionnaire, which consists of 24 items across 3 subscales: knowledge, behaviour, and attitude. Each item is rated on a 3-point Likert scale: 3 (agree); 2 (indecisive); 1 (disagree). Interval Scales with a total range of 24-72, and the mean of the fluid control scale at every time observation per person. Higher scores indicate better fluid adherence.

    Measured: At Baseline before intervention, midle of intervention at week four, and after completing the intervention at week 9

  2. Hemodialysis Self-Management Behaviours

    Patient completes a self-reported HDSMI-18 (Hemodialysis Self-Management Instrument-18) questionnaire covering 4 subscales: partnership, self-care, problem solving, and emotional management. Each item is rated on a 4-point Likert scale: 1 = never, 2 = rarely, 3 = sometimes, 4 = always. Interval Scales with a total range of 18-72, and the mean of self-management scores at every time observation per person. Higher scores indicate better self-management behaviour.

    Measured: At baseline before intervention, midle of intervention at week four, and after completing the intervention at week 9

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Model description
Group education sessions led by the principal investigator; individual education sessions led by the principal investigator and nurses trained in hemodialysis nursing education; and behavioral intervention strategies based on the Individual and Family Self-Management Theory. Follow-up social support sessions via a WhatsApp channel were conducted by the principal investigator and a designated research team. To maintain the principle of blinding, the selected research team will help monitor the number of participants who respond with emojis and submit their digital diaries. If entries are incomplete, the research team will contact the participants to have them completed. The designated research team has undergone training in accordance with the principles of this intervention study. The training covered standardization of the intervention protocol, motivational communication, IFSMT principles, and patient counseling skills.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07677605
Sponsor's protocol ID
NTUNHS22052026
Other IDs
Self Funding
Status last verified
Jun 2026
First submitted
17 Jun 2026
Last updated
1 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be publicly available due to ethical and confidentiality restrictions imposed by the participating instituitions and the informed consent agreement signed by participants

Questions about this trial

What is this clinical trial studying?

A study testing A Theory-based fluid self-management program in people with Hemodialysis Patient, run by National Taipei University of Nursing and Health Sciences at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cornelia Dede Yoshima Nekada, PhD Candidate (+628121444251, lia.nekada@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Interdialytic Weight Gain (time frame: Each participant's hemodialysis sessions over an eight-month period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in